Viavi Solutions (VIAV) director Joanne Solomon sells 10,000 shares at $42.92

Rhea-AI Filing Summary

VIAVI SOLUTIONS INC. director Joanne Solomon sold 10,000 shares of common stock on 2026-08-14 in open-market or private transactions at a weighted average price of $42.92 per share, with individual trade prices ranging from $42.88 to $43.04.

Following this sale, Solomon directly holds 65,924 shares of VIAVI common stock. The transaction is not reported as made under a Rule 10b5-1 trading plan and was executed in multiple trades.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Solomon Joanne

Role Director

Sold 10,000 shs ($429K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	10,000	$42.92	$429K

Holdings After Transaction: Common Stock — 65,924 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $42.88 to $43.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $42.92 per share Trade price range: $42.88 to $43.04 per share +1 more

4 metrics

Shares sold 10,000 shares Common stock sold by director Joanne Solomon on 2026-08-14

Weighted average sale price $42.92 per share Weighted average price for the 10,000-share sale

Trade price range $42.88 to $43.04 per share Price range of individual trades in the reported sale

Shares held after transaction 65,924 shares Direct holdings of Joanne Solomon after the sale

Key Terms

weighted average sale price, open market or private transaction, Rule 10b5-1

3 terms

weighted average sale price financial

"The price reported above reflects the weighted average sale price."

open market or private transaction financial

"Transaction code description: Sale in open market or private transaction"

Rule 10b5-1 regulatory

"The transaction is not reported as made under a Rule 10b5-1 trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did VIAVI (VIAV) director Joanne Solomon report?

Joanne Solomon reported a sale of 10,000 VIAVI common shares on 2026-08-14. The transaction was coded as an open-market or private sale and executed in multiple trades at prices between $42.88 and $43.04 per share.

At what price did VIAVI (VIAV) shares sell in Joanne Solomon’s Form 4 filing?

The reported transaction used a weighted average sale price of $42.92 per share. Individual trades were executed at prices ranging from $42.88 to $43.04, with the insider offering to provide detailed trade breakdowns upon request.

How many VIAVI (VIAV) shares does Joanne Solomon hold after the reported sale?

After selling 10,000 shares, Joanne Solomon directly holds 65,924 shares of VIAVI common stock. This post-transaction holding reflects only the position reported in this Form 4 and relates to her direct ownership stake.

Was the VIAVI (VIAV) insider sale by Joanne Solomon under a Rule 10b5-1 plan?

The Form 4 indicates the transaction was not affirmed under a Rule 10b5-1 trading plan. The document’s 10b5-1 checkbox is marked as not applicable, and no footnote describes the sale as pursuant to a pre-arranged trading plan.

What does the Form 4 for VIAVI (VIAV) say about the structure of Joanne Solomon’s trade prices?

The sale was executed in multiple trades with prices between $42.88 and $43.04. The reported $42.92 figure is a weighted average sale price, and the insider undertakes to provide full trade details to regulators or shareholders upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 02:36 PM Accepted by SEC EDGAR 08/14/2026 - 02:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Solomon Joanne

(Last) (First) (Middle)

C/O VIAVI SOLUTIONS INC.

1445 SOUTH SPECTRUM BLVD, SUITE 102

(Street)

CHANDLER ARIZONA 85286

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VIAVI SOLUTIONS INC. [ VIAV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2026		S		10,000	D	$42.92(1)	65,924	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $42.88 to $43.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Donna T. Rossi, attorney-in-fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)